Literature DB >> 16154242

Prevalence of childhood exanthematic disease antibodies in paramedical students: need of vaccination.

Andrea Trevisan1, Marta Morandin, Clara Frasson, Paolo Paruzzolo, Elisabetta Davanzo, Livio Di Marco, Andrea Fabrello, Matteo Borella-Venturini.   

Abstract

The immunity to common childhood exanthematic diseases such as varicella, rubella, mumps and measles was evaluated in 1024 students of the degree courses of health professions at Padua University Medical School. Subjects were subdivided according to gender and age (25 years old or less, and older than 25 years). Results showed that the prevalence of positive antibodies (IgG) to varicella and rubella (94.1 and 94.5%, respectively) was significantly higher (p<0.001) than mumps (78.6%) and measles (86.3%). In addition, measles showed a significant higher prevalence than mumps (p<0.001). Prevalence of positive antibodies to rubella in females (97.4%) was significantly higher (p<0.001) than males (87.5%), but only if aged 25 years or less. Furthermore, males older than 25 years were significantly more immune (p<0.001) to measles (93.0%) than younger ones (84.3%). A vaccination strategy was applied but compliance was less than 50%; in addition, about 40.0% of vaccinated subjects eluded control after vaccination. Seroconversion after vaccine appeared high for rubella, mumps and measles (92.3, 88.9 and 88.1%, respectively), but low for varicella (43.8%).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16154242     DOI: 10.1016/j.vaccine.2005.07.062

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  High seroprevalence of varicella, measles, mumps, rubella and pertussis antibodies in first-grade medical students.

Authors:  Maja Socan; Natasa Berginc
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

Review 2.  A global perspective of vaccination of healthcare personnel against measles: systematic review.

Authors:  Amy Parker Fiebelkorn; Jane F Seward; Walter A Orenstein
Journal:  Vaccine       Date:  2013-11-24       Impact factor: 3.641

3.  Incidence and effects of Varicella Zoster Virus infection on academic activities of medical undergraduates--a five-year follow-up study from Sri Lanka.

Authors:  Suneth B Agampodi; Samath D Dharmaratne; Vasanthi Thevanesam; Sameera Dassanayake; Prabhashini Kumarihamy; Ashani Ratnayake
Journal:  BMC Infect Dis       Date:  2010-05-14       Impact factor: 3.090

4.  Seroprevalence of antibodies against varicella zoster virus and rubella virus among newly recruited expatriate healthcare workers: a cross-sectional study.

Authors:  Ibrahim Shady
Journal:  BMJ Open       Date:  2018-03-22       Impact factor: 2.692

5.  Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization.

Authors:  Margarita Riera-Montes; Kaatje Bollaerts; Ulrich Heininger; Niel Hens; Giovanni Gabutti; Angel Gil; Bayad Nozad; Grazina Mirinaviciute; Elmira Flem; Audrey Souverain; Thomas Verstraeten; Susanne Hartwig
Journal:  BMC Infect Dis       Date:  2017-05-18       Impact factor: 3.090

6.  Coronary Artery Dilation in Children with Febrile Exanthematous Illness without Criteria for Kawasaki Disease.

Authors:  Jesus Reyna; Luz Marina Reyes; Lorenzo Reyes; Freya Helena Campos; Patricia Meza; Alfredo Lagunas; Carla Contreras; Ana Elena Limón
Journal:  Arq Bras Cardiol       Date:  2019-12       Impact factor: 2.000

7.  Vaccination and Immunity toward Measles: A Serosurvey in Future Healthcare Workers.

Authors:  Andrea Trevisan; Paola Mason; Annamaria Nicolli; Stefano Maso; Bruno Scarpa; Angelo Moretto; Maria Luisa Scapellato
Journal:  Vaccines (Basel)       Date:  2021-04-13

8.  Response to Vaccination against Mumps in Medical Students: Two Doses Are Needed.

Authors:  Andrea Trevisan; Angelo Moretto; Chiara Bertoncello; Annamaria Nicolli; Stefano Maso; Maria Luisa Scapellato; Paola Mason
Journal:  Viruses       Date:  2021-07-07       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.